Evaluation of Diaphragmatic Function After Interscalene Block With Liposomal Bupivacaine
Recruiting now · Not applicable
Conditions studied: Diaphragmatic Function, Metacarpal Fracture, Radius Fracture, Peripheral Nerve Neurolysis, Chronic Ulcer, Upper Extremity Ligament Injury
In brief
The study aims to evaluation the effects of Liposomal Bupivacaine on diaphragmatic function in patients undergoing upper limb surgery who receive Interscalene Brachial Plexus Block. A total of 120 eligible patients will be enrolled and divided into two groups: Group A will receive 20ml of 0.5% Hydrochloride Bupivacaine , while Group B will receive 10ml of 0.5% Hydrochloride Bupivacaine plus 10ml of Liposomal Bupivacaine. Assessments of diaphragmatic function, pulmonary function, and pain intensity will be performed before the block and at different time points after the block, with follow-up for adverse events. The study is scheduled to run from September 2025 to September 2026, with strict adherence to privacy protection and ethical guidelines.
Key facts
- Study ID
- NCT07263295
- Run by
- Zhejiang University
- People needed
- 120
- Starts
- 2025-12-05
- Expected to finish
- 2026-08-25
- Last updated by the study team
- 2026-08-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients undergoing upper limb surgery scheduled for interscalene brachial plexus block
- Aged ≥ 18 years
- American Society of Anesthesiologists (ASA) physical status I-III
You may not qualify if…
- Known allergy or intolerance to amide local anesthetics
- Nerve injury in the upper limb on the surgical side
- Coagulopathy
- Used opioid medications continuously for more than 3 weeks before surgery
- History of pulmonary disease and a pulse oxygen saturation (SpO₂) < 95% (measured after 5 minutes of rest at room temperature without oxygen supplementation, using a transcutaneous pulse oximeter)
- Refuse to participate or are deemed unsuitable for this trial by the researchers
- Withdrawal Criteria:
- Patients voluntarily withdrew their informed consent
- Surgery was canceled or the anesthesia method was changed due to surgical factors before interscalene brachial plexus block
Where it is running
- The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, zhejiang 310000 — Hangzhou, Zhejiang, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.